Mary W. Redman - Concepedia

Author

Mary W. Redman

Also Known As

M Redman, M W Redman, M. Redman, M. W. Redman, M.W. Redman, Mary Redman, Mary W Redman, Mary W. Redman, Mary Weber Redman

435

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of California, Davis The University of Texas MD Anderson Cancer Center UC Davis Comprehensive Cancer Center University of Washington

About

Mary W. Redman is an author at Fred Hutch Cancer Center specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	42	1.7K
2	Health Sciences	12	13	369
3	Public Health	4	4	208
4	Biostatistics	3	3	57
5	Engineering	2	2	251

Mary W. Redman

100

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Incidence of Suicide in Persons With Cancer Stephanie Misono, Noel S. Weiss, Jesse R. Fann, Journal of Clinical Oncology	2008	600
Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124 Primo N. Lara, Ronald B. Natale, John Crowley, Journal of Clinical Oncology	2009	517
T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas Seth M. Pollack, Qianchuan He, Jennifer H. Yearley, Cancer	2017	257
Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400 Roy S. Herbst, David R. Gandara, Fred R. Hirsch, Clinical Cancer Research EngineeringBiomarker-driven ProtocolAdvanced Lung DiseaseLung Master ProtocolPathology	2015	232
Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A Karen L. Reckamp, Mary W. Redman, Konstantin H. Dragnev, Journal of Clinical Oncology	2022	228
Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach Mary W. Redman, Catherine M. Tangen, Phyllis J. Goodman, Cancer Prevention Research	2008	203
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC Julia Kargl, Xiaodong Zhu, Huajia Zhang, JCI Insight	2019	183
Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials Primo N. Lara, Mary W. Redman, Karen Kelly, Journal of Clinical Oncology	2008	181
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study Kelly G. Paulson, Christopher W. Lewis, Mary W. Redman, Cancer	2016	175
Equal Plasma Viral Loads Predict a Similar Rate of CD4<sup>+</sup>T Cell Decline in Human Immunodeficiency Virus (HIV) Type 1– and HIV‐2–Infected Individuals from Senegal, West Africa Geoffrey S. Gottlieb, Papa Salif Sow, Stephen E. Hawes, The Journal of Infectious Diseases	2002	148

Page 1